Pregnancy
Conditions
Keywords
placental protein, gestational age, abortion
Brief summary
This will be a case-series multicenter study enrolling 800 pregnant people. Serum will be collected from people seeking abortion and assayed at a qualified laboratory.
Detailed description
Knowledge of gestational age (GA) is essential for guiding abortion care. In 2016, Gynuity Health Projects (GHP) launched a portfolio of research that aims to explore the possibility of developing a blood or urine test for this purpose.The goal of the present study is to validate initial study findings (protocol 8000) in a larger population of people seeking abortion. Staff will obtain a serum specimen from each participant before any cervical manipulation is performed and before any abortifacient drug is administered. The site will send the specimens to a central facility for storage until assay. Serum assays for PAPP-A and possibly other proteins will be performed at a selected laboratory by qualified experts.
Interventions
no intervention, just specimen collection
Sponsors
Study design
Eligibility
Inclusion criteria
* Pregnant and seeking medical or surgical abortion * Has had or will have an ultrasound on the day of study enrollment or earlier during the current pregnancy * Able to provide blood and urine specimens before any trans-cervical procedure or mifepristone ingestion * Not previously enrolled in this study
Exclusion criteria
* Does not meet Inclusion Criteria
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Negative Predictive Value 70 days | 1 day | Negative Predictive Value of Prespecified Protein Concentration in Serum for Predicting a GA of ≤70 days is \>95% |
| Negative Predictive Value 105 days | 1 day | Negative Predictive Value of Prespecified Protein Concentration in Serum for Predicting a GA of ≤105 days is \>95% |
Countries
United States